Two cases of severe intoxication associated with analytically confirmed use of the novel psychoactive substances 25B-NBOMe and 25C-NBOMe

High-performance liquid chromatography tandem mass spectrometry method for the determination of 2CC-NBOMe and 25I-NBOMe in human serum

(2013) Justin L. Poklis et al.   BIOMEDICAL CHROMATOGRAPHY

A case of 25I-NBOMe (25-I) intoxication: a new potent 5-HT2A agonist designer drug

(2013) S. Rutherfoord Rose et al.   CLINICAL TOXICOLOGY

Severe clinical toxicity associated with analytically confirmed recreational use of 25I–NBOMe: case series

(2013) Simon L. Hill et al.   CLINICAL TOXICOLOGY

Emerging Drugs of Abuse

(2013) Michael E. Nelson et al.   EMERGENCY MEDICINE CLINICS OF NORTH AMERICA

Drug Abuse

(2012) Gregory G. Davis   CLINICS IN LABORATORY MEDICINE

25C-NBOMe – New potent hallucinogenic substance identified on the drug market

(2012) Dariusz Zuba et al.   FORENSIC SCIENCE INTERNATIONAL

Clinical toxicology of newer recreational drugs

(2011) Simon L. Hill et al.   CLINICAL TOXICOLOGY

2C-T-4 intoxication: Acute psychosis caused by a designer drug

(2008) Miho Miyajima et al.   PSYCHIATRY AND CLINICAL NEUROSCIENCES